Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study

Article Type
Changed
Thu, 01/10/2019 - 12:38
Display Headline
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study

Article PDF
Author and Disclosure Information

Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M

Issue
Cutis - 83(6)
Publications
Topics
Page Number
299-302
Legacy Keywords
erythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Studyerythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Study, Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M
Sections
Author and Disclosure Information

Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M

Author and Disclosure Information

Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M

Article PDF
Article PDF

Issue
Cutis - 83(6)
Issue
Cutis - 83(6)
Page Number
299-302
Page Number
299-302
Publications
Publications
Topics
Article Type
Display Headline
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study
Display Headline
Erythema Dyschromicum Perstans: Successful Treatment With Clofazimine Under a Single-Patient Investigational New Drug Study
Legacy Keywords
erythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Studyerythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Study, Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M
Legacy Keywords
erythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Studyerythema, dyschromia, clofazinmine, EDP, hypermelanosis, New Drug Study, Micciantuono SR, Cardona L, Pinzon-Plazas M, Rendon M
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Mequinol 2%/Tretinoin 0.01% Topical Solution for the Treatment of Melasma in Men: A Case Series and Review of the Literature

Article Type
Changed
Thu, 01/10/2019 - 12:13
Display Headline
Mequinol 2%/Tretinoin 0.01% Topical Solution for the Treatment of Melasma in Men: A Case Series and Review of the Literature

Article PDF
Author and Disclosure Information

Keeling J, Cardona L, Benitez A, Epstein R, Rendon M

Issue
Cutis - 81(2)
Publications
Topics
Page Number
179-183
Sections
Author and Disclosure Information

Keeling J, Cardona L, Benitez A, Epstein R, Rendon M

Author and Disclosure Information

Keeling J, Cardona L, Benitez A, Epstein R, Rendon M

Article PDF
Article PDF

Issue
Cutis - 81(2)
Issue
Cutis - 81(2)
Page Number
179-183
Page Number
179-183
Publications
Publications
Topics
Article Type
Display Headline
Mequinol 2%/Tretinoin 0.01% Topical Solution for the Treatment of Melasma in Men: A Case Series and Review of the Literature
Display Headline
Mequinol 2%/Tretinoin 0.01% Topical Solution for the Treatment of Melasma in Men: A Case Series and Review of the Literature
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Combining Topical Therapy With Procedures to Treat Hyperpigmentation Disorders

Article Type
Changed
Thu, 01/10/2019 - 12:43
Display Headline
Combining Topical Therapy With Procedures to Treat Hyperpigmentation Disorders

Article PDF
Author and Disclosure Information

Keeling J, Cardona L, Rendon M

Issue
Cutis - 79(4)
Publications
Topics
Page Number
223-228
Sections
Author and Disclosure Information

Keeling J, Cardona L, Rendon M

Author and Disclosure Information

Keeling J, Cardona L, Rendon M

Article PDF
Article PDF

Issue
Cutis - 79(4)
Issue
Cutis - 79(4)
Page Number
223-228
Page Number
223-228
Publications
Publications
Topics
Article Type
Display Headline
Combining Topical Therapy With Procedures to Treat Hyperpigmentation Disorders
Display Headline
Combining Topical Therapy With Procedures to Treat Hyperpigmentation Disorders
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media